Access VetMed has unveiled a European veterinary medicine manifesto, a policy document intended to shape how the profession engages with legislators and regulators across the continent.

The manifesto is the coalition's most concrete step yet in its push to influence the direction of veterinary medicine in Europe. By publishing a formal set of priorities, Access VetMed moves from advocacy in principle to advocacy on paper — the kind of document that campaigns typically circulate in Brussels and in national capitals in the run-up to European Parliament elections and policy reviews.

For veterinarians in practice, the significance lies in what comes next. Manifestos of this kind typically serve as lobbying blueprints: they signal to policymakers which regulatory questions the profession wants reopened, and they give national associations a shared reference point when they press their own governments. Whether Access VetMed's priorities gain traction will depend on the coalition's ability to translate the document into formal submissions to the European Commission, the European Medicines Agency (EMA), and national competent authorities.

The publication also lands at a moment when European veterinary regulation is under sustained pressure from several directions. The revised veterinary medicines regulation, applied across the EU since January 2022, changed the rules governing antimicrobial use, prescription practices, and the availability of medicines in food-producing animals. Practitioners continue to report friction points, particularly around drug shortages and the harmonization of prescribing rules between member states. Any manifesto addressing European veterinary medicine will be measured against whether it engages those operational realities or stays at the level of general principle.

The document's release also frames a broader question about representation. European veterinary medicine has multiple advocacy voices — practitioner associations, industry bodies, and regulatory-facing groups — and a new manifesto inevitably competes for attention within that field. Access VetMed's document will be read by national associations and by individual clinics as a statement of what the coalition stands for and whose interests it claims to represent.

For companion-animal practices, the practical stakes center on issues such as telemedicine rules, cross-border recognition of qualifications, and access to authorized products. For food-animal and mixed practices, the sharper questions involve antimicrobial stewardship obligations, the cascade for prescribing, and the availability of older but clinically essential products that manufacturers have withdrawn for commercial rather than safety reasons. Public-health implications run through both: zoonotic disease surveillance, antimicrobial resistance policy, and the veterinary profession's statutory role in food safety all depend on decisions made at the European level.

What the manifesto cannot do by itself is change any of those outcomes. Documents of this type function as agenda-setting instruments. They acquire force only when professional bodies cite them, when regulators respond to them, and when the coalition behind them sustains the follow-through — consultations, position papers, and direct engagement with policymakers — that turns stated priorities into legislative or regulatory language.

Veterinarians and practice owners across Europe now have a reference document they can evaluate against their own operating conditions. The next observable test will be the response from European institutions and national associations, and whether Access VetMed converts the manifesto into formal participation in the regulatory processes it seeks to influence.